证券之星消息，截至2025年12月9日收盘，和仁科技(300550)报收于13.66元，上涨1.64%，换手率 2.14%，成交量5.62万手，成交额7720.93万元。 12月9日的资金流向数据方面，主力资金净流出25.69万元，占总成交额0.33%，游资资金净流入22.44万 元，占总成交额0.29%，散户资金净流入3.25万元，占总成交额0.04%。 近5日资金流向一览见下表： 资金流向名词解释：指通过价格变化反推资金流向。股价处于上升状态时主动性买单形成的成交额是推 动股价上涨的力量，这部分成交额被定义为资金流入，股价处于下跌状态时主动性卖单产生的的成交额 是推动股价下跌的力量，这部分成交额被定义为资金流出。当天两者的差额即是当天两种力量相抵之后 剩下的推动股价上升的净力。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流 向。 注：主力资金为特大单成交，游资为大单成交，散户为中小单成交 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 该股主要指标及行业内排名如下： 和仁科技2025年三季报显示，前三季度公司主 ...

Core Viewpoint - The stock of HeRen Technology (300550) has shown a slight increase, with a closing price of 12.17 yuan on October 21, 2025, reflecting a 2.44% rise, amidst mixed capital flows [1] Financial Performance - HeRen Technology reported a main revenue of 159 million yuan for the first half of 2025, a year-on-year decrease of 0.99% [3] - The net profit attributable to shareholders was -3.52 million yuan, an increase of 75.44% year-on-year [3] - The company's gross profit margin stood at 43.41%, slightly below the industry average of 44.48% [3] - The second quarter of 2025 saw a single-quarter main revenue of 80.48 million yuan, a year-on-year increase of 16.11% [3] - The net profit for the second quarter was 324,100 yuan, a significant year-on-year increase of 102.35% [3] Market Position - HeRen Technology's total market capitalization is 3.195 billion yuan, significantly lower than the software development industry average of 13.155 billion yuan [3] - The company ranks 151st out of 194 in terms of total market capitalization within its industry [3] - The price-to-earnings ratio (P/E) is -453.89, indicating negative earnings, while the industry average is 82.81 [3] Capital Flow Analysis - On October 21, 2025, the net inflow of main funds was 2.3979 million yuan, accounting for 8.18% of the total transaction amount [2] - Retail investors showed a net inflow of 354,000 yuan, representing 1.21% of the total transaction amount [2] - Over the past five days, the stock has experienced fluctuations in capital flow, with notable net outflows from speculative funds [2]

Group 1 - The core viewpoint of the news is that HeRen Technology's stock price has increased by 6.02% to 14.79 yuan, with a rolling PE ratio of 77.50, marking a new low in 114 days, and a total market value of 3.883 billion yuan [1] - The average PE ratio for the software development industry is 147.99, with a median of 90.70, placing HeRen Technology at the 125th position in the industry ranking [1] - On August 22, the net inflow of main funds into HeRen Technology was 12.53 million yuan, although there has been an overall outflow of 658,600 yuan over the past five days [1] Group 2 - HeRen Technology specializes in the research, sales, implementation integration, and service support of medical information systems and digital scenario application systems [1] - The latest performance report for the first half of 2025 shows that the company achieved an operating income of 159 million yuan, a year-on-year decrease of 0.99%, and a net profit of -3,519,977.27 yuan, a year-on-year increase of 75.44%, with a sales gross margin of 43.41% [1] - The PE (TTM) for HeRen Technology is 77.50, while the static PE is 98.82, and the price-to-book ratio is 3.53 [2]

Group 1 - The stock price of Madi Technology as of August 4, 2025, is 15.15 yuan, down 0.51 yuan or 3.26% from the previous trading day [1] - The opening price for the day was 15.41 yuan, with a highest price of 15.41 yuan and a lowest price of 14.48 yuan, and the trading volume reached 277,818 hands with a transaction amount of 412 million yuan [1] - Madi Technology is in the software development industry, focusing on medical information technology and artificial intelligence, providing products such as medical information systems and clinical information systems primarily for medical institutions [1] Group 2 - Madi Technology is expected to turn a profit in the first half of 2025, indicating a positive shift in financial performance [1] - The company is included in the humanoid robot concept stocks, attracting market attention due to its industry chain layout [1] - On August 4, the net outflow of main funds from Madi Technology was 66.585 million yuan, accounting for 1.43% of the circulating market value, with a cumulative net outflow of 267.6486 million yuan over the past five days, representing 5.77% of the circulating market value [1]

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Zhejiang Heren Technology Co., Ltd., which closed at 13.49 yuan with a PE ratio of 98.47 times, while the industry average PE is 120.22 times [1][2] - The company's total market capitalization is 3.542 billion yuan, ranking 144th in the software development industry based on PE ratio [1][2] - The company experienced a net outflow of 1.0375 million yuan in principal funds on July 8, but had a total inflow of 2.5346 million yuan over the past five days [1] Group 2 - Heren Technology's main business involves the research, sales, implementation integration, service support, and solution provision for clinical medical information systems and digital application systems [1] - The latest financial report for Q1 2025 shows the company achieved operating revenue of 78.3961 million yuan, a year-on-year decrease of 13.99%, and a net profit loss of 3.844103 million yuan, a year-on-year decline of 645.00% [1] - The company's gross profit margin stands at 32.76% [1]

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of HeRen Technology, indicating a significant decline in revenue and profit for Q1 2025 compared to the previous year [1][2] - HeRen Technology's stock closed at 13.43 yuan, with a PE ratio of 98.03, which is below the industry average of 117.07 and the median of 85.14 [1][2] - The company has a total market capitalization of 3.526 billion yuan, ranking 146th in the software development industry based on PE ratio [1][2] Group 2 - As of Q1 2025, five institutions hold shares in HeRen Technology, with a total of 13.85358 million shares valued at 1.818 billion yuan [1] - The company's main business involves the research, sales, implementation, and support of clinical medical information systems and digital application systems [1] - The latest financial report shows a revenue of 78.3961 million yuan, a year-on-year decrease of 13.99%, and a net profit loss of 3.844103 million yuan, reflecting a 645% decline [1]